samatasvir (IDX719) - Merck (MSD)
Idenix: Cowen & Company Healthcare Conference (Idenix) - Mar 6, 2014 - Anticipated initiation of P2 samatasvir + IDX21437 combo trial for hep C infection in H2 2014; Anticipated SVR4 data from P2 samatasvir + IDX21437 combo trial for hep C infection in H2 2014 
Anticipated new P2 trial • Anticipated P2 data Hepatitis C Virus
http://wsw.com/webcast/cowen16/IDIX/
 
Mar 6, 2014
 
.
 
c76e4dcc-3dcc-4036-87fe-10b6d0ca931c.jpg